{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:12:49Z","timestamp":1788225169174,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Blumenau-L\u00e9onie-Hartmann Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-023-04317-y","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T15:02:46Z","timestamp":1676559766000},"page":"1125-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1931-0952","authenticated-orcid":false,"given":"Manolis","family":"Pratsinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautier","family":"M\u00fcllhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"G\u00fcsewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Betschart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Zumstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Engeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair D.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Abt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"Suppl 1","key":"4317_CR1","first-page":"82","volume":"22","author":"SM Nair","year":"2015","unstructured":"Nair SM, Pimentel MA, Gilling PJ (2015) Evolving and investigational therapies for benign prostatic hyperplasia. Can J Urol 22(Suppl 1):82\u201387","journal-title":"Can J Urol"},{"key":"4317_CR2","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2020.12.019","volume":"79","author":"S Malde","year":"2021","unstructured":"Malde S, Umbach R, Wheeler JR, Lytvyn L, Cornu JN, Gacci M et al (2021) A systematic review of patients\u2019 values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms. Eur Urol 79:796\u2013809","journal-title":"Eur Urol"},{"key":"4317_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/luts.12415","volume":"14","author":"MW Yao","year":"2022","unstructured":"Yao MW, Green JSA (2022) How international is the International Prostate Symptom Score? A literature review of validated translations of the IPSS, the most widely used self-administered patient questionnaire for male lower urinary tract symptoms. Low Urin Tract Symptoms 14:92\u2013101","journal-title":"Low Urin Tract Symptoms"},{"key":"4317_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0022-5347(05)65985-X","volume":"166","author":"MD Eckhardt","year":"2001","unstructured":"Eckhardt MD, van Venrooij GE, van Melick HH, Boon TA (2001) Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 166:563\u2013568","journal-title":"J Urol"},{"key":"4317_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/pri.36","volume":"11","author":"S Ashford","year":"2006","unstructured":"Ashford S, Turner-Stokes L (2006) Goal attainment for spasticity management using botulinum toxin. Physiother Res Int 11:24\u201334","journal-title":"Physiother Res Int"},{"key":"4317_CR6","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/AOG.0b013e3181b2b1ae","volume":"114","author":"MD Barber","year":"2009","unstructured":"Barber MD, Brubaker L, Nygaard I, Wheeler TL 2nd, Schaffer J, Chen Z et al (2009) Defining success after surgery for pelvic organ prolapse. Obstet Gynecol 114:600\u2013609","journal-title":"Obstet Gynecol"},{"key":"4317_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ajog.2005.08.043","volume":"194","author":"ST Mahajan","year":"2006","unstructured":"Mahajan ST, Elkadry EA, Kenton KS, Shott S, Brubaker L (2006) Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 194:722\u2013728","journal-title":"Am J Obstet Gynecol"},{"key":"4317_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jnnp.73.5.500","volume":"73","author":"K Rockwood","year":"2002","unstructured":"Rockwood K, Graham JE, Fay S, Investigators A (2002) Goal setting and attainment in Alzheimer\u2019s disease patients treated with donepezil. J Neurol Neurosurg Psychiatry 73:500\u2013507","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4317_CR9","volume-title":"Development of a self-assessment goal achievement (SAGA) questionnaire in urinary disorders","author":"L Brubaker","year":"2007","unstructured":"Brubaker L, Kopp Z, Piault E, Trocio J, Evans C, Fitzgerald K et al (2007) Development of a self-assessment goal achievement (SAGA) questionnaire in urinary disorders. International Continence Society, Rotterdam"},{"key":"4317_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00192-011-1382-7","volume":"22","author":"L Brubaker","year":"2011","unstructured":"Brubaker L, Khullar V, Piault E, Evans CJ, Bavendam T, Beach J et al (2011) Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the self-assessment goal achievement (SAGA) questionnaire. Int Urogynecol J 22:937\u2013946","journal-title":"Int Urogynecol J"},{"key":"4317_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/ijcp.12087","volume":"67","author":"L Brubaker","year":"2013","unstructured":"Brubaker L, Piault EC, Tully SE, Evans CJ, Bavendam T, Beach J et al (2013) Validation study of the self-assessment goal achievement (SAGA) questionnaire for lower urinary tract symptoms. Int J Clin Pract 67:342\u2013350","journal-title":"Int J Clin Pract"},{"key":"4317_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1477-7525-10-40","volume":"10","author":"E Piault","year":"2012","unstructured":"Piault E, Doshi S, Brandt BA, Ang\u00fcn \u00c7, Evans CJ, Bergqvist A et al (2012) Linguistic validation of translation of the self-assessment goal achievement (saga) questionnaire from English. Health Qual Life Outcomes 10:40","journal-title":"Health Qual Life Outcomes"},{"key":"4317_CR13","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","volume":"199","author":"P Gilling","year":"2018","unstructured":"Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T et al (2018) WATER: a double-blind, randomized, controlled trial of aquablation\u00ae vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199:1252\u20131261","journal-title":"J Urol"},{"key":"4317_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.euf.2022.04.005","volume":"8","author":"D Abt","year":"2022","unstructured":"Abt D, Lyatoshinsky P, Schmid H-P, M\u00fcllhaupt G (2022) Prostatic artery embolisation: do we still need it and for whom? Eur Urol Focus 8:384\u2013387","journal-title":"Eur Urol Focus"},{"key":"4317_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2338","volume":"361","author":"D Abt","year":"2018","unstructured":"Abt D, Hechelhammer L, M\u00fcllhaupt G, Markart S, G\u00fcsewell S, Kessler TM et al (2018) Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ 361:k2338","journal-title":"BMJ"},{"key":"4317_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s42155-019-0049-1","volume":"2","author":"S Young","year":"2019","unstructured":"Young S, Golzarian J (2019) Prostate embolization: patient selection, clinical management and results. CVIR Endovascular 2:7","journal-title":"CVIR Endovascular"},{"key":"4317_CR17","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/bmj.314.7094.1564","volume":"314","author":"DM Berwick","year":"1997","unstructured":"Berwick DM (1997) Medical associations: guilds or leaders? BMJ 314:1564\u20131565","journal-title":"BMJ"},{"key":"4317_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/00005392-200101000-00008","volume":"165","author":"BS Wadie","year":"2001","unstructured":"Wadie BS, Ibrahim EH, de la Rosette JJ, Gomha MA, Ghoneim MA (2001) The relationship of the international prostate symptom score and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail. J Urol 165:32\u201334","journal-title":"J Urol"},{"key":"4317_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.urology.2006.02.046","volume":"68","author":"D Marschall-Kehrel","year":"2006","unstructured":"Marschall-Kehrel D, Roberts RG, Brubaker L (2006) Patient-reported outcomes in overactive bladder: the influence of perception of condition and expectation for treatment benefit. Urology 68:29\u201337","journal-title":"Urology"},{"key":"4317_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1590\/s1677-5538.ibju.2019.0411","volume":"46","author":"AK Das","year":"2020","unstructured":"Das AK, Teplitsky S, Chandrasekar T, Perez T, Guo J, Leong JY et al (2020) Stress urinary incontinence post-holmium laser enucleation of the prostate: a single-surgeon experience. Int Braz J Urol 46:624\u2013631","journal-title":"Int Braz J Urol"},{"key":"4317_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0895-4356(03)00132-X","volume":"56","author":"K Rockwood","year":"2003","unstructured":"Rockwood K, Howlett S, Stadnyk K, Carver D, Powell C, Stolee P (2003) Responsiveness of goal attainment scaling in a randomized controlled trial of comprehensive geriatric assessment. J Clin Epidemiol 56:736\u2013743","journal-title":"J Clin Epidemiol"},{"key":"4317_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/NCC.0000000000000567","volume":"42","author":"K Adellund Holt","year":"2019","unstructured":"Adellund Holt K, Hansen DG, Mogensen O, Jensen PT (2019) Self-assessment of goal achievements within a gynecological cancer rehabilitation counseling. Cancer Nurs 42:58\u201366","journal-title":"Cancer Nurs"},{"key":"4317_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1023\/B:EJEP.0000036568.02655.f8","volume":"19","author":"V Kristman","year":"2004","unstructured":"Kristman V, Manno M, C\u00f4t\u00e9 P (2004) Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol 19:751\u2013760","journal-title":"Eur J Epidemiol"},{"key":"4317_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203825","volume":"13","author":"MC Cho","year":"2018","unstructured":"Cho MC, Kim JK, Ha SB, Ku JH, Paick JS (2018) Self-assessed goal achievement (SAGA) after Holmium laser enucleation of the prostate (HoLEP): association with patients\u2019 postoperative satisfaction. PLoS\u00a0One 13:e0203825","journal-title":"PLoS\u00a0One"},{"key":"4317_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M et al (2006) Symptom assessment tool for overactive bladder syndrome\u2013overactive bladder symptom score. Urology 68:318\u2013323","journal-title":"Urology"},{"key":"4317_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMp1707537","volume":"377","author":"LS Rotenstein","year":"2017","unstructured":"Rotenstein LS, Huckman RS, Wagle NW (2017) Making patients and doctors happier\u2014the potential of patient-reported outcomes. N Engl J Med 377:1309\u20131312","journal-title":"N Engl J Med"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04317-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04317-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04317-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T11:07:35Z","timestamp":1683198455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04317-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04317-y","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment\/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: (please list all conflict of interest with the relevant author\u2019s name): Manolis Pratsinis currently receives funding from the Swiss Cancer Research Foundation (BIL KFS-5248-02-2021). He has previously received education support from Janssen Pharmaceutica. Gautier M\u00fcllhaupt currently receives funding from Blumenau-L\u00e9onie-Hartmann Foundation. Sabine G\u00fcsewell has no financial disclosures or conflicts of interest to declare. Patrick Betschart has previously received education support from Janssen Pharmaceutica. Valentin Zumstein has no financial disclosures or conflicts of interest to declare. Daniel Engeler has no financial disclosures or conflicts of interest to declare. Hans-Peter Schmid has no financial disclosures or conflicts of interest to declare. Alastair Lamb currently receives funding from Cancer Research UK (C57899\/A25812) and the Oxford NIHR Biomedical Research Centre Surgical Innovation & Evaluation theme. He has previously received grant funding from Prostate Cancer UK (PA14-022), The Academy of Medical Sciences (SGCL11), Medical Research Council (CiC), National Institute of Health Research and GlaxoSmithKline. He has received education support from Astellas, Lilly, AstraZeneca and Ipsen. He is a stipendiary BJUI Section Editor for Prostate Cancer and has received honoraria for reviewing for European Urology and Lancet Oncology. He has received consulting fees from AlphaSights. Domink Abt has no financial disclosures or conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethics committee (EKOS 21\/084).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}